Assessment of potential drug interactions by characterization of human drug metabolism pathways using non-invasive bile sampling.
about
Pharmacokinetics, pharmacodynamics and adverse event profile of GSK2256294, a novel soluble epoxide hydrolase inhibitorThe pharmacokinetics and pharmacodynamics of danirixin (GSK1325756)--a selective CXCR2 antagonist --in healthy adult subjects.Evaluation of a New Molecular Entity as a Victim of Metabolic Drug-Drug Interactions-an Industry Perspective.Fasiglifam (TAK-875): Mechanistic Investigation and Retrospective Identification of Hazards for Drug Induced Liver Injury.Adding value through accelerator mass spectrometry-enabled first in human studies.Human absorption, distribution, metabolism and excretion properties of drug molecules: a plethora of approaches
P2860
Assessment of potential drug interactions by characterization of human drug metabolism pathways using non-invasive bile sampling.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Assessment of potential drug i ...... ng non-invasive bile sampling.
@ast
Assessment of potential drug i ...... ng non-invasive bile sampling.
@en
type
label
Assessment of potential drug i ...... ng non-invasive bile sampling.
@ast
Assessment of potential drug i ...... ng non-invasive bile sampling.
@en
prefLabel
Assessment of potential drug i ...... ng non-invasive bile sampling.
@ast
Assessment of potential drug i ...... ng non-invasive bile sampling.
@en
P2093
P2860
P1476
Assessment of potential drug i ...... ng non-invasive bile sampling.
@en
P2093
Aili L Lazaar
Alison Webb
Bruce E Miller
Claire Beaumont
Jackie C Bloomer
William J Guiney
P2860
P304
P356
10.1111/J.1365-2125.2012.04352.X
P407
P577
2013-02-01T00:00:00Z